{
    "title": "113_s557",
    "content": "The \"Medication Therapy Management Empowerment Act of 2013\" improves access to medication therapy management under Part D of the Medicare program. The Social Security Act is amended to expand the definition of targeted beneficiaries, with a report due on the potential reduction in expenditures by January 1, 2014. The Social Security Act is amended to expand the definition of targeted beneficiaries by including single chronic diseases like diabetes, hypertension, heart failure, and dyslipidemia. The Chief Actuary must report on the potential reduction in expenditures by January 1, 2014. The Social Security Act is amended to include single chronic diseases like diabetes, hypertension, heart failure, dyslipidemia, respiratory disease, bone disease-arthritis, rheumatoid arthritis, and mental health conditions. The Chief Actuary must report on potential expenditure reduction by January 1, 2014. Expansion of healthcare coverage under the Social Security Act, effective from January 1, 2015, requires a report from the Chief Actuary by March 1, 2020, analyzing the implementation of the expansion. The expansion of healthcare coverage under the Social Security Act requires a report from the Chief Actuary by March 1, 2020, to determine if the expansion reduces spending. If it is found that the expansion does not reduce spending, the Secretary may terminate the expansion starting from January 1, 2021. The Secretary will consider if expanding healthcare coverage improves care quality and health outcomes for individuals in a medication therapy management program."
}